Sponsor
TILT Biotherapeutics Oy
Tukholmankatu 8b, 00290 Helsinki, Finland
About the sponsor
TILT Biotherapeutics Oy is active in oncolytic adenovirus research centered on TILT-123 and its use in injectable tumors. The sponsor’s clinical portfolio reflects a focus on virus-based approaches for direct tumor targeting and immune activation.
- Oncolytic adenovirus
- TILT-123
- Injectable solid tumors
The research interest extends to tumor types where local administration and immune engagement are relevant, with studies involving melanoma and other accessible solid malignancies.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.